203 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
19 Oct 23
Current report (foreign)
1:45pm
Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
4 Oct 23
RepliCel Provides Default Status Update and Announces Shareholder Approval of Equity Incentive Plan
2:23pm
.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.2
54r1d42ablnv v83xm
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
uh6jm2h
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
njw1 vatr3kap6w
7 Sep 23
Current report (foreign)
12:26pm
6-K
EX-99.2
uhmj5hf6n63e46hgn 8v
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.1
wvz tk8dh9kt
29 Aug 23
RepliCel announces the passing of long time Chief Financial Officer Simon Ma; David Kwok is appointed Chief Financial Officer
1:14pm
6-K
EX-99.4
ynb 5va47nm3jw3p22ec
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.2
vqa6 gf2chs
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.1
yrsdd
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.1
9r2ci ao3yuwuq6f
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
uu61ni kip76c
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
6-K
EX-99.5
ks39l7o
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
yiwf5cz kxrrfn
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
xp4cdcg57c4ua2ct
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.2
rwd d732oxev2st
25 Oct 22
Current report (foreign)
12:27pm